These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38491080)

  • 1. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
    Guan Z; Liu J; Zheng L
    Sci Rep; 2024 Mar; 14(1):6304. PubMed ID: 38491080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
    Alsner J; Sørensen SB; Overgaard J
    Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
    Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
    J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
    Alsner J; Høyer M; Sørensen SB; Overgaard J
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
    Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
    Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.
    Huang CS; Hsieh MS; Yadav VK; Wu YC; Liu SC; Yeh CT; Huang MS
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
    Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of
    Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 14. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
    Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
    Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
    Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy.
    Rong C; Grünow J; Thierauf J; Lucena-Porcel C; Major G; Holzinger D; Dyckhoff G; Kern J; Lammert A; Scherl C; Rotter N; Plinkert PK; Affolter A
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
    Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
    Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-211-3p enhances induction chemotherapy insensitivity by upregulating CSF2/CCL20/TNF signaling in hypopharyngeal squamous cell carcinoma.
    Wang L; Wang R; Huang T; Yang Y; Feng L; Fang J
    Mol Biol Rep; 2022 Jul; 49(7):6103-6112. PubMed ID: 35397087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
    Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
    PeerJ; 2023; 11():e16237. PubMed ID: 37842043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.